Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Androgen glycosides improve oral absorption of active ingredient

Dec. 5, 2000

Bayer prepares new compounds active against HCMV

Dec. 5, 2000

Thrombopoietin mimics emerge from SmithKline Beecham R&D

Dec. 5, 2000

Anticancer tyrosine kinase inhibitors covered in patent issued to American Cyanamid

Dec. 5, 2000

Novel diagnostic agents targeting dopamine and 5-HT transporters

Dec. 5, 2000

Novel series of tricyclic osteogenesis promoters patented by Taisho

Dec. 4, 2000

Korean researchers discover new series of protein farnesyltransferase inhibitors

Dec. 4, 2000

Kyowa Hakko reveals newest inhibitors of PDE5 and their potential therapeutic applications

Dec. 4, 2000

Japanese patent covers new steroidal antiproliferative compounds identified at Kaneka

Dec. 4, 2000

Carbapenems with good oral bioavailability prepared by Sankyo researchers

Dec. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...